ClinicalTrials.gg
RecruitingNCT06829732CLOC-INUpdated Feb 17, 2025

Closed Loop Oxygen Control in INtubated Critically Ill Patients

An interventional study of closed-loop oxygen control (CLOC) and 2. manual oxygen titration (MOT) in Hypoxemic Acute Respiratory Failure, sponsored by Parc Taulí Hospital Universitari. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-17.

Sponsored by Parc Taulí Hospital Universitari · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Registered 9 months after the study started (first participant enrolled Apr 2023, registered Jan 2024).
  • Started Apr 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The deleterious effects of alveolar hyperoxia and (severe) hyperoxaemia are well described. Achieving safe and efficient oxygenation may be challenging. The hypothesis of the present study is that closed-loop oxygen control in intubated and mechanically ventilated critically ill patients improves oxygen administration compared with standard manual oxygen titrations. A single-blind, randomised crossover clinical trial assessing the efficacy and safety of the use of a closed-loop oxygen control versus manual oxygen titration in patients receiving mechanical ventilation has been designed. Patients will be randomised to receive first either closed-loop oxygen control (CLOC) or manual oxygen titration (MOT). The percentage of time spent in optimal and sub-optimal SpO2 (oxygen saturation by pulse oximetry) ranges will be calculated for each period.

Read the detailed description

The deleterious effects of alveolar hyperoxia and (severe) hyperoxaemia are well described. A safe and efficient oxygenation should be achieved. However, from a practical point of view, this may require frequent manual adjustments of the inspired oxygen, which might be unfeasible, especially in high-demand periods. Several automatic oxygen systems have been tested in non-intubated patients. The hypothesis of the present study is that closed-loop oxygen control in intubated and mechanically ventilated critically ill patients improves oxygen administration compared with standard manual oxygen titrations. Thus, the objective of the study is to compare the percentage of time spent in a predefined optimal SpO2 range between closed-loop oxygen control and manual oxygen titration.

A single-blind, randomised crossover clinical trial assessing the efficacy and safety of the use of a closed-loop oxygen control versus manual oxygen titration in patients receiving mechanical ventilation has been designed. Once included, patients will be randomised to receive first either closed-loop oxygen control (CLOC) or manual oxygen titration (MOT). Every period will last for 4h. Clinical and respiratory variables will be recorded. A memory box will be connected to the patient's ventilator. This device will record ventilator parameters, including FiO2 and SpO2. To assess the outcome, the percentage of time spent in optimal and sub-optimal SpO2 ranges will be calculated for each period.

02

Conditions studied

  • Hypoxemic Acute Respiratory Failure
03

In context

Respiratory Insufficiency

1,675 studies on the registry are indexed under Respiratory Insufficiency; 300 are open to participants now.

This study's planned enrollment of 46 is below the median of 55 across 1,056 interventional studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

Parc Taulí Hospital Universitari is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients admitted to the ICU who are expected to require invasive mechanical ventilation for at least 8 hours and are expected to stay respiratory stable´ in the upcoming 8 hours.
  • Acute respiratory failure with PaO2/FiO2 \<300 with FiO2 ≥ 0.4 at inclusion
  • Age older than 18 years old.
  • Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation.

Exclusion criteria

Exclusion Criteria:

  • Low quality on the SpO2 measurement using finger and ear sensor (quality index \<60%).
  • Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine > 1 mg/h.
  • Severe acidosis (pH ≤ 7.30).
  • Chronic or acute dyshemoglobinemia: methemoglobin, CO poisoning, sickle cell disease.
  • Patient under guardianship or deprived of liberties.
  • Impossibility to give informed consent by both patient and family (i.e. language barrier).
  • Patient included in another interventional research study under consent with similar outcome.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    1. closed-loop oxygen control (CLOC)

    Automatic Oxygen management sets the Oxygen control according to the patient's measured SpO2 and the operator-set SpO2 target range during 4h.

    Device: closed-loop oxygen control (CLOC)

  • Active comparator
    2. manual oxygen titration (MOT)

    Conventional oxygen manual management according to SpO2 target range set by clinician, during 4h.

    Device: 2. manual oxygen titration (MOT)

Interventions

  • Deviceclosed-loop oxygen control (CLOC)

    HAMILTON-C6 (Hamilton Medical, Bonaduz, Switzerland) ventilators will be used. It allows for O2 Assist software, that will be installed on all C6 ventilators before the start of this study. Automatic Oxygen management sets the Oxygen control according to the patient's measured SpO2 and the operator-set SpO2 target range. The Oxygenation controller will be activated for 4h and adjusts the Oxygen according to patient's measured SpO2.

  • Device2. manual oxygen titration (MOT)

    O2 will be manually set according to SpO2 target during a 4h period.

06

What researchers measure

Primary outcomes

  1. Efficacy outcome:

    To compare the percentage of time spent in a predefined optimal SpO2 (oxygen saturation by pulse oximetry) range between closed-loop oxygen control and manual oxygen titration

    Time frame: Hour 1 to 4

Secondary outcomes

  1. Percentage of time with SpO2 (oxygen saturation by pulse oximetry) in sub-optimal ranges

    To compare the percentage of time with SpO2 in sub-optimal ranges, above and below the optimal range, during closed-loop oxygen control and manual oxygen titration

    Time frame: Hour 1 to 4

  2. Percentage of time with SpO2 (oxygen saturation by pulse oximetry) out of range

    To compare the percentage of time with SpO2 out of range, above and below the optimal and sub-optimal range.

    Time frame: Hour 1 to 4

  3. Number of manual adjustments

    To compare the number of manual adjustments

    Time frame: Hour 1 to 4

  4. Mean SpO2/FiO2 (oxygen saturation by pulse oximetry to fraction of inspired oxygen ratio) between the two methods

    To compare the mean SpO2/FiO2 between the two methods of oxygen titration

    Time frame: Hour 1 to 4

  5. Mean FiO2 (fraction of inspired oxygen) between the two methods of oxygen titration

    To compare the mean FiO2 between the two methods of oxygen titration

    Time frame: Hour 1 to 4

  6. Time with FiO2 (fraction of inspired oxygen) below 40%

    To compare the percentage of time with FiO2 below 40%

    Time frame: Hour 1 to 4

  7. Time with FiO2 (fraction of inspired oxygen) above 60%

    To compare the percentage of time with FiO2 above 60%

    Time frame: Hour 1 to 4

  8. Time with FiO2 (fraction of inspired oxygen) at 100%

    To compare the percentage of time with FiO2 at 100%

    Time frame: Hour 1 to 4

  9. SpO2 (oxygen saturation by pulse oximetry) below 88 and 85%.

    To compare the percentage of time with SpO2 below 88 and 85%.

    Time frame: Hour 1 to 4

  10. SpO2 (oxygen saturation by pulse oximetry) below 88 and 85% (Event > 10s and 60 s)

    To compare the number of events with SpO2 below 88 and 85% (Event \> 10s and 60 s)

    Time frame: Hour 1 to 4

  11. Number of alarms

    To compare the number of alarms

    Time frame: Hour 1 to 4

  12. Time with SpO2 (oxygen saturation by pulse oximetry) signal available.

    To compare the percentage of time with SpO2 signal available.

    Time frame: Hour 1 to 4

  13. Total amount of oxygen used

    To compare the total amount of oxygen used (in L)

    Time frame: Hour 1 to 4

07

Study locations

1 of 1 sites recruiting
  • Parc Tauli Hospital Universitary
    Sabadell, Barcelona 08028, Spain
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06829732
Lead sponsor
Parc Taulí Hospital Universitari
Responsible party
Oriol Roca (Director of Critical Care Department, Corporacion Parc Tauli) — Principal investigator
First posted
Feb 17, 2025
Start date
Apr 1, 2023
Primary completion
Mar 2025 (estimated)
Completion
Mar 2025 (estimated)
Last update
Feb 17, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion